Richard Peters
Chairman at APREA THERAPEUTICS, INC.
Net worth: 39 336 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paula Ragan | M | 54 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 years |
| Shawn Iadonato | M | 54 | 16 years | |
| Sijmen de Vries | M | 65 | 16 years | |
| Katherine Bowdish | M | 67 |
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | 4 years |
| David Arkowitz | M | 62 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | 2 years |
| Oren Gilad | M | 56 | 2 years | |
| John Hamill | M | 60 | 1 years | |
| Kimberlee Drapkin | F | 55 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | 1 years |
| Michael Levitan | M | 66 | - | |
| Michael Grissinger | M | 70 | 2 years | |
| Matthew Busch | M | 50 | 20 years | |
| Marion Foote | F | 78 | 7 years | |
| Ruud van Outersterp | M | 60 | 4 years | |
| Deborah Jorn | F | 66 | 5 years | |
| David Reese | M | 61 | 19 years | |
| Marc Duey | M | 68 | 2 years | |
| Raymond Bartoszek | M | - | 7 years | |
| Scott Dylla | M | - | 1 years | |
| Mireille Sanders | F | 56 | 5 years | |
| Gabriela Gruia | M | 67 | 1 years | |
| Leonard Kruimer | M | 66 | 3 years | |
| Rifat Pamukcu | M | 66 | 2 years | |
| John Henneman | M | 62 | 5 years | |
| Bernd Seizinger | M | 67 | 9 years | |
| Robert Eckert | M | 69 | 21 years | |
| Pritesh Gandhi | M | - |
Tellbio, Inc.
 Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | - |
| Paulash Mohsen | M | - |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Stephen Toor | M | 52 | 4 years | |
| Anurag Relan | M | 52 | - | |
| Jabine T. M. van der Meijs | M | 58 | 3 years | |
| Thierry Guillaudeux | M | 55 | 4 years | |
| Annie Partisano | M | - |
Tellbio, Inc.
Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | - |
| Gary Crocker | M | 72 |
Tellbio, Inc.
Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | - |
| Barbara Yanni | F | 69 | 4 years | |
| Steven Baert | M | 50 | 3 years | |
| Jean Bizzari | M | 69 | 1 years | |
| Craig Philips | M | 64 | 11 years | |
| Bernard F. Peters | M | 59 |
Tellbio, Inc.
Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | - |
| Keith Baker | M | 57 | 2 years | |
| Derek Miller | M | - | 21 years | |
| N. Coles | M | 63 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Lynne Zydowsky | M | 65 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Mark Pykett | M | 60 | 4 years | |
| Jeroen Wakkerman | M | 55 | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henri A. Termeer | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 34 years |
| Michael Kelly | M | 67 | 17 years | |
| Christian Schade | M | 63 | 7 years | |
| Jean Franchi | F | 57 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 19 years |
| Yasir Al-Wakeel | M | 42 | 2 years | |
| Paul Eisenberg | M | - | 14 years | |
| Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| David W. Beier | M | 75 | 10 years | |
| Scott Rocklage | M | 69 | 4 years | |
| William A. Sullivan | M | 52 | 10 years | |
| Sun Altbach | F | - |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | 2 years |
| Paul Sekhri | M | 65 | 8 years | |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Cynthia Patton | F | 62 | 15 years | |
| Pauline Kenny | F | 51 | 12 years | |
| Diana McKenzie | F | 59 | 12 years | |
| Scott Coiante | M | 57 | 4 years | |
| Josias Fantato De Pontes | M | 58 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Gregory L. Tewalt | M | - | - | |
| Michael Severino | M | 58 | 10 years | |
| Craig Shepherd | M | - | 7 years | |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
| Daryl C. Drummond | M | - | - | |
| Gregory Korbel | M | 48 | 7 years | |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
| Erin Lavelle | F | 46 | 15 years | |
| Gavin MacBeath | M | 54 | 24 years | |
| Yamo Deniz | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
| Willard Dere | M | 70 | 11 years | |
| Susan Lundeen Smuck | F | 57 | 12 years | |
| Peter Radovich | M | 46 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Leonard Schaeffer | M | 78 | 9 years | |
| Guido Magni | M | 70 | 4 years | |
| Sean B. W. Martin | M | 61 | - | |
| Marilyn E. Wortzman | F | 77 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 9 years |
| Michael Porter | M | 76 | 8 years | |
| David J. Scott | M | 71 | - | |
| Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
| Timothy Martin | M | 55 | 3 years | |
| Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Frank Herringer | M | 81 | 15 years | |
| Anna Richo | F | 63 | - | |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
| Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Patricia Cary Sueltz | F | 71 | 2 years | |
| William Sibold | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| George Demetri | M | 67 | 2 years | |
| Alison Lawton | F | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 25 years |
| Roger W. Louis | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| John Smither | M | 71 | 6 years | |
| Jin Long Chen | M | 61 | 4 years | |
| Jonathan Hepple | M | 53 | 5 years | |
| Cynthia Flowers | F | 64 | 5 years | |
| Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| William Ashton | M | 73 | 16 years | |
| Michael Wyzga | M | 35 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 86.00% |
| Netherlands | 14 | 14.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Peters
- Personal Network